InsidersTradesSigma
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Stock: price and management transactions · Hong Kong · HKEX
Follow the Jiangsu Hengrui Pharmaceuticals Co., Ltd. share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Jiangsu Hengrui Pharmaceuticals Co., Ltd. has logged 7 insider filings. Market capitalisation: €346.8bn. The latest transaction was disclosed on 29 April 2026 (Other). Among the most active insiders: Lou Liguang. The full history is accessible without an account.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Jiangsu Hengrui Pharmaceuticals Co., Ltd. Buy (bullish), based on 9 analysts. Average price target: HK$96.82.
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,834 of 26,211 companies
61.5
score / 100
Value33
Quality90
FCF yld2.1%
Earn yld2.0%
EV/EBITDA41.2x
ROE15%
Gross mgn86%
Net mgn24%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 April 2026
Declarations7 total
1,000 sharesShareXHKGHKEX:DA20260428E00444
10,180 sharesShareXHKGHKEX:DA20260428E00443
99,000 sharesShareXHKGHKEX:DA20260402E00226
81,000 sharesShareXHKGHKEX:DA20260402E00275
49,000 sharesShareXHKGHKEX:DA20260402E00289
81,000 sharesShareXHKGHKEX:DA20260402E00267
7 of 7 declarations